These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35217400)

  • 21. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
    Mroz EA; Patel KB; Rocco JW
    Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based Long-term Outcomes for Squamous Cell Carcinoma of the Nasal Cavity.
    Hamilton SN; Liu J; Holmes C; DeVries K; Olson R; Tran E; Berthelet E; Wu J; Chau N; Chan M; Thamboo A
    Am J Clin Oncol; 2023 May; 46(5):199-205. PubMed ID: 36882926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma.
    Li J; Qiu R; Hu Y; Wang Y; Qi Z; He M; Li Y
    Biomed Res Int; 2021; 2021():8571438. PubMed ID: 33553432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma.
    Song T; Chen P; Fang M; Zhang X; Du D; Wu S
    Cancer Manag Res; 2020; 12():1631-1639. PubMed ID: 32184666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019.
    Justesen MM; Stampe H; Jakobsen KK; Andersen AO; Jensen JM; Nielsen KJ; Gothelf AB; Wessel I; Christensen A; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 Feb; 149():106684. PubMed ID: 38211527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base.
    Graboyes EM; Zhan KY; Garrett-Mayer E; Lentsch EJ; Sharma AK; Day TA
    Cancer; 2017 Jun; 123(12):2248-2257. PubMed ID: 28182267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Postoperative Radiotherapy on the Prognosis of Early-Stage (pT1-2N0M0) Oral Tongue Squamous Cell Carcinoma.
    Tian Q; Jiang L; Dai D; Liu L; Shi X; Guo Y; Wu D; Yang J; Xu J; Cai Z; Ye Z; Xi Y; Zheng Z; Li H; Shui Y; Liu Y; Shang J; Wei S; Wei Q
    J Clin Oncol; 2024 May; 42(15):1754-1765. PubMed ID: 38560819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma.
    Qiu Z; Wu Z; Zhou X; Lin M; Su Y; Tao Y
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):195. PubMed ID: 38625410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review and individual patient data analysis of pediatric head and neck squamous cell carcinoma: An analysis of 217 cases.
    Bhanu Prasad V; Mallick S; Upadhyay AD; Rath GK
    Int J Pediatr Otorhinolaryngol; 2017 Jan; 92():75-81. PubMed ID: 28012539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis on surgery with or without postoperative radiotherapy to treat squamous cell esophageal carcinoma.
    Lin HN; Chen LQ; Shang QX; Yuan Y; Yang YS
    Int J Surg; 2020 Aug; 80():184-191. PubMed ID: 32659390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary surgery for advanced-stage laryngeal cancer: A stage and subsite-specific survival analysis.
    Harris BN; Bhuskute AA; Rao S; Farwell DG; Bewley AF
    Head Neck; 2016 Sep; 38(9):1380-6. PubMed ID: 27014858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
    Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
    Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
    Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
    JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of Tumor Size, Subsite, and Adjuvant Therapy on Outcomes in pT4aN0 Oral Cavity Carcinoma.
    Namin AW; Bollig CA; Harding BC; Dooley LM
    Otolaryngol Head Neck Surg; 2020 May; 162(5):683-692. PubMed ID: 32069171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.
    Cheraghlou S; Schettino A; Zogg CK; Otremba MD; Bhatia A; Park HS; Osborn HA; Mehra S; Yarbrough WG; Judson BL
    Laryngoscope; 2019 Apr; 129(4):883-889. PubMed ID: 30151947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.
    Harari PM; Harris J; Kies MS; Myers JN; Jordan RC; Gillison ML; Foote RL; Machtay M; Rotman M; Khuntia D; Straube W; Zhang Q; Ang K
    J Clin Oncol; 2014 Aug; 32(23):2486-95. PubMed ID: 25002723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.